Institution
Monroe Carell Jr. Children's Hospital at Vanderbilt
Healthcare•
About: Monroe Carell Jr. Children's Hospital at Vanderbilt is a based out in . It is known for research contribution in the topics: Population & Medicine. The organization has 1046 authors who have published 1262 publications receiving 28063 citations. The organization is also known as: Vanderbilt Children's Hospital.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Withdrawal of immunosuppressive therapy, followed by curative intent chemotherapy should be offered to all patients who relapse after an allogeneic HSCT, and a second HSCT should be considered, especially in patients who respond to salvage chemotherapy.
Abstract: Relapse after allogeneic hematopoietic SCT (HSCT) carries a poor prognosis and is a common cause of death. Outcomes of children who relapse post HSCT are not well known. In this retrospective multicenter study we included 532 patients who underwent allogeneic HSCT and examined the outcomes of 160 patients (30%) who relapsed. Treatment options after relapse included (i) palliative therapy with non-curative intent (n=43), (ii) salvage chemotherapy (without a second HSCT, n=55) or (iii) salvage chemotherapy followed by a second HSCT (n=62). Sixty two patients underwent a second HSCT. The 1-year disease-free survival (DFS) for those given palliative therapy, chemotherapy alone and who underwent a second transplant was <1%, 9% and 50% (P=<0.0001), respectively. The DFS at 1 and 2 year was 50% and 35%, respectively, among the patients who received a second transplant versus 9% and 2% in those who did not (P=<0.0001). In multivariable analysis longer time to relapse (P=0.04) and undergoing a second HSCT (P<0.001) were associated with improved outcome. Withdrawal of immunosuppressive therapy, followed by curative intent chemotherapy should be offered to all patients who relapse after an allogeneic HSCT. A second HSCT should be considered, especially in patients who respond to salvage chemotherapy.
23 citations
••
TL;DR: Publishing of national pneumonia guidelines in 2011 was associated with modest changes in diagnostic testing for children with CAP, however, the changes varied across hospitals, and the financial impact was modest.
Abstract: BACKGROUND
National guidelines for the management of community-acquired pneumonia (CAP) in children were published in 2011. These guidelines discourage most diagnostic testing for outpatients, as well as repeat testing for hospitalized patients who are improving. We sought to evaluate the temporal trends in diagnostic testing associated with guideline implementation among children with CAP.
METHODS
Children 1 to 18 years old who were discharged with pneumonia after emergency department (ED) evaluation or hospitalization from January 1, 2008 to June 30, 2014 at any of 32 children's hospitals participating in the Pediatric Health Information System were included. We excluded children with complex chronic conditions and those requiring intensive care or who underwent early pleural drainage. We compared use of diagnostic testing (blood culture, complete blood count [CBC], C-reactive protein [CRP], and chest radiography [CXR]) before and after release of the guidelines, and assessed for temporal trends using interrupted time series analysis. We also calculated the cost impact of these changes on diagnostic utilization and evaluated the variability of the guideline's impact across hospitals.
RESULTS
Overall, 220,539 patients were included; 53% were male and the median age was 4 years (interquartile range, 2–7). For patients discharged from the ED with CAP, diagnostic utilization rates for blood culture, CBC, CRP, and CXR were higher after guideline publication compared with expected utilization rates without guidelines. In contrast, initial testing and repeat testing among patients hospitalized with CAP was lower after guideline publication. There were modest reductions in estimated costs associated with these changes. However, wide variability was observed in the impact of the guidelines across hospitals.
CONCLUSIONS
Publication of national pneumonia guidelines in 2011 was associated with modest changes in diagnostic testing for children with CAP. However, the changes varied across hospitals, and the financial impact was modest. Local implementation efforts are warranted to ensure widespread guideline adherence. Journal of Hospital Medicine 2016. © 2016 Society of Hospital Medicine
23 citations
••
TL;DR: The pyloric ratio can be a highly sensitive, specific, and weight independent indicator of hypertrophic pylori stenosis.
Abstract: We sought to define a weight independent, highly sensitive and specific measurement to diagnose hypertrophic pyloric stenosis. A retrospective review of 87 children was performed. We determined the pyloric ratio (wall thickness/pyloric diameter) and its relationship to weight and compared it to standard criteria. The average pyloric ratios in normal children and in those with hypertrophic pyloric stenosis were 0.205 and 0.325, respectively (P < 0.001). A pyloric ratio of 0.27 yielded a sensitivity and specificity of 96% and 94%, respectively. The pyloric ratio maintained a linear relationship to weight in normal patients and those with hypertrophic pyloric stenosis. We conclude the pyloric ratio can be a highly sensitive, specific, and weight independent indicator of hypertrophic pyloric stenosis.
23 citations
••
TL;DR: The history of NIV, the rationale for its use, and the evidence of efficacy in both the adult and pediatric literature are reviewed as well as new trends in noninvasive respiratory support.
Abstract: Noninvasive ventilation (NIV) refers to the delivery of ventilatory support using techniques that do not require an endotracheal airway. Noninvasive ventilation is being used with increased frequency in a variety of clinical situations in the emergency department, intensive care unit, and prehospital environment. This article reviews the history of NIV, the rationale for its use, and the evidence of efficacy in both the adult and pediatric literature. This article also describes equipment and techniques currently available for administration of NIV as well as new trends in noninvasive respiratory support.
23 citations
••
TL;DR: The findings of a prospective, longitudinal cohort study of acute respiratory illness in children attending daycare argue against the hypothesis that HBoV is a primary respiratory pathogen, leaving the biological significance of H BoV infection in question.
Abstract: In this issue of the Journal, Martin et al. report the results of a prospective, longitudinal cohort study of acute respiratory illness (ARI) in children attending daycare [1]. This article describes prolonged shedding of the recently identified human bocavirus (HBoV) by children and detection of HBoV in the absence of respiratory symptoms. Their findings argue against the hypothesis that HBoV is a primary respiratory pathogen, leaving the biological significance of HBoV infection in question. The work also nicely illustrates a common problem facing modern virologists: how to assign disease causality to a microorganism that is not amenable to Koch's postulates. Molecular discovery techniques have indentified numerous viruses that, like HBoV, have yet to be definitively established as pathogens.
23 citations
Authors
Showing all 1056 results
Name | H-index | Papers | Citations |
---|---|---|---|
Dan M. Roden | 132 | 859 | 67578 |
Kathryn M. Edwards | 102 | 628 | 39467 |
Agnes B. Fogo | 98 | 578 | 38840 |
James E. Crowe | 83 | 430 | 22045 |
Luc Van Kaer | 79 | 261 | 26242 |
John A. Phillips | 69 | 270 | 16980 |
Louis J. Muglia | 68 | 254 | 15777 |
Douglas B. Johnson | 65 | 331 | 18439 |
Keith T. Wilson | 63 | 238 | 13002 |
Michael R. DeBaun | 62 | 369 | 14812 |
Simon W. Hayward | 61 | 191 | 13131 |
Wendy L. Stone | 61 | 150 | 17231 |
Arnold W. Strauss | 60 | 209 | 10792 |
Dominique Delbeke | 59 | 170 | 14652 |
Thomas B. Newman | 58 | 239 | 11638 |